Tag: SFA

Endologix announces completion of enrollment in TORUS 2 study for PAD...

Endologix has completed enrollment in the TORUS 2 investigational device exemption (IDE) clinical study in the U.S., a press release reports. The TORUS 2 study...

IN.PACT Admiral DCB performs well across wide range of clinical, anatomical...

In a pooled analysis of the predictors of drug-coated balloon (DCB) effectiveness, the IN.PACT Admiral DCB (Medtronic) performed well across a broad range of clinical, anatomical...